IDEAYA Biosciences (IDYA) Cash from Investing Activities (2018 - 2026)

IDEAYA Biosciences (IDYA) has 9 years of Cash from Investing Activities data on file, last reported at $119.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 49.03% year-over-year to $119.0 million; the trailing twelve-month figure through Mar 2026 stood at $109.1 million (up 258.66% YoY), and the FY2025 full-year result was $70.0 million, up 113.92% from the prior year.
• Cash from Investing Activities rose to $119.0 million in Q1 2026, from -$97.5 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $119.0 million in Q1 2026 to a low of -$354.0 million in Q1 2024.
• A 5-year average of -$29.7 million and a median of -$10.3 million in 2022 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities sank 2388.14% in 2022 and surged 374.83% in 2023, its largest moves.
• Tracing IDYA's Cash from Investing Activities over 5 years: stood at -$10.3 million in 2022, then plunged by 989.36% to -$111.9 million in 2023, then slumped by 76.08% to -$197.1 million in 2024, then soared by 50.52% to -$97.5 million in 2025, then jumped by 221.97% to $119.0 million in 2026.
• Business Quant data shows IDYA's Cash from Investing Activities at $119.0 million in Q1 2026, -$97.5 million in Q4 2025, and $41.8 million in Q3 2025.